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06 The Journal of Thoracic and Cardiobjective: We have analyzed, in a clinical multicenter study, the effect of cardiac
urgery in adults with congenital heart disease in Italy.
ethods: We collected clinical data from 856 patients aged 19 years or older who
nderwent surgical intervention from January 1, 2000, to December 31, 2004.
atients were divided into 3 surgical groups: group 1, palliation (3.1%); group 2,
epair (69.7%); and group 3, reoperation (27.4%).
esults: Preoperatively, 34.6% of patients were in New York Heart Association
lass I, 48.4% were in class II, 14.2% were in class III, and 2.8% were in class IV.
inus rhythm was present in 83%. There were 1179 procedures performed in 856
atients (1.37 procedures per patient), with a hospital mortality of 3.1%. Overall
ean intensive care unit stay was 2.3 days (range, 1–102 days). Major complica-
ions were reported in 247 (28.8%) patients, and postoperative arrhythmias were the
ost frequent. At a mean follow-up of 22 months (range, 1 month–5.5 years;
ompleteness, 87%), late death occurred in 5 (0.5%) patients. New York Heart
ssociation class was I in 79.3%, II in 17.6%, and III in 2.9%, and only 1 (0.11%)
atient was in class IV. Overall survival estimates are 82.6%, 98.9%, and 91.8% at
years for groups 1, 2, and 3, respectively. Freedom from adverse events at 5 years
s 91% for acyanotic patients versus 63.9% for preoperative cyanotic patients (P 
0001).
onclusions: Surgical intervention for congenital heart disease in adults is a safe and
ow-risk treatment. However, patients presenting with preoperative cyanosis show a
igher incidence of late adverse events and complications.
ongenital heart malformations are currently treated in pediatric patients.
However, adults and adolescents with congenital heart disease are becoming
an important entity because recent improved diagnostic and therapeutic
ools allow the majority of newborns with congenital heart disease (CHD) to survive
o adulthood.1 Currently, adults with CHD in Italy are calculated to number
pproximately 80,000.2 Thus, the effect of such a huge population on the medical
ommunity is expected to be relevant.
For this reason, we have designed a multicenter study involving 7 major Italian
ardiac centers, to evaluate the early and midterm outcomes of cardiac surgery in
his particular group in our country.
aterials and Methods
ll major congenital cardiac centers in Italy (12) were invited to be part of this study in a 5-year
ime frame under the supervision of the Italian Society of Cardiology. Seven centers joined the
tudy by sending complete data and respecting requirements as indicated in a preset database. The
atabase was designed based on demographic, pathologic, surgical, and postoperative data, as
equested in the EACTS Congenital Database (www.eactscongenitaldb.org). There is no age
vascular Surgery ● July 2007
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Destriction in this database as far as the data collection is con-
erned. All centers are medium-high surgical volume centers, with
he number of cases ranging between 200 and 450 cases per year.
ll the participating centers are tertiary level national centers. Five
f the 7 centers have a cardiac transplantation program, and 2
enters are authorized for heart-lung transplantation. Data were
ollected by one of the authors in every center, and all material was
alidated by the coordinating authors (M.A.P. and G.S., Padua).
Eight hundred fifty-six patients were enrolled who underwent
perations for a variety of CHDs between January 1, 2000, and
ecember 31, 2004. The male/female ratio was 1.13 (455 men
53.2%] and 401 women [46.8%]). Age ranged between 18 and 80
ears (mean, 37.2 years; median, 34.2 years). Diagnoses, proce-
ures, extracardiac anomalies, preoperative risk factors, and post-
perative complications were classified according to the EACTS
ongenital Database classification, as described elsewhere.3 Diag-
oses were divided into “anatomic” (as the basic heart malforma-
ion) and “leading to surgical intervention” (as the cause for
peration, regardless of the basic anatomy) categories (Table E1).
Surgical procedures (intended as a surgical procedure for a
ingle major congenital cardiac lesion; more than one surgical
rocedure might be associated in the same operation in the same
atient with a complex congenital cardiac lesion) were arbitrarily
ivided into 3 groups: group 1, palliative procedures, defined as
ny operation performed to improve the patient’s clinical status
ithout restoring normal anatomy or physiology (Table 1); group
, repair procedures, defined as any operation designed to achieve
n anatomic or physiologic correction resulting in a separation of
he pulmonary from the systemic circulation (we have included in
his group the Fontan-type repair and the one-and-a-half ventricle
epair; Table 2); and group 3, reoperation, defined as any cardiac
urgical procedure after either physiologic or anatomic repair
Table 3).
Follow-up was based on clinical data derived from the Con-
enital Heart Disease in Adults database followed by each center,
hich considers onset of adverse events listed as follows: late
Abbreviations and Acronyms
ASD  atrial septal defect
CHD  congenital heart disease
HR  hazard ratio
NYHA New York Heart Association
ABLE 1. Palliative procedures
alliative procedure %
idirectional cavopulmonary anastomosis
(Glenn procedure)
20.7
ulmonary artery banding 13.8
urgical ablation 10.3
lalock–Taussig shunt 10.3
ystemic–to–pulmonary artery shunt
ligation and takedown
3.4ther procedures (miscellaneous) 41.4 O
The Journal of Thoracicardiac death, late noncardiac death, reoperation, interventional
ardiology procedure, and “other.”
Survival estimates for all patients were analyzed with the
aplan–Meier method applied to the main cardiac lesion (atrial
eptal defect [ASD], right heart lesion, left heart lesion, and single
entricle) and to the main lesion stratified in the 3 different
perative categories (palliation, repair, and reoperation). The effect
f preoperative functional New York Heart Association (NYHA)
lass III and IV, with or without associated cyanosis, was similarly
valuated. Statistically significant incremental (hazard ratio [HR],
1.0) or decremental (HR, 1.0) risk factors were identified by
eans of a forward stepwise (P to enter  .05, P to remain  .2)
ABLE 2. Repair procedures
urgical procedure %
trial septal defect closure 36.1
artial anomalous pulmonary venous
connection repair
7.2
entricular septal defect closure 5.4
oss operation 5.3
trioventricular septal defect–partial
type repair
5.1
ricuspid valve plasty 4.8
ortic valve replacement 3.7
ubaortic stenosis resection 3.2
ortic repair 2.4
itral valve plasty 2.2
urgical ablation 2.2
ight ventricular outflow tract
procedure
2.1
ortic coarctation repair 2
etralogy of Fallot repair 1
itral valve replacement 0.7
ther procedures 16.6
ABLE 3. Reoperations
eoperation %
onduit reoperation 9.9
ortic valve replacement 7.7
ulmonary valve replacement 6.8
entricular septal defect 4.6
ricuspid valve plasty 4.3
ight ventricular outflow tract procedure 4
ubaortic stenosis resection 3.7
ortic aneurysm repair 3.7
trial septal defect closure 3.4
itral valve replacement 3.1
eart transplantation 2.5
ulmonary artery plasty 2.2
ight ventricle–pulmonary artery conduit 2.2
ortic coarctation repair 1.9
oss procedure 1.5
itral valve plasty 1.5ther 25.3
and Cardiovascular Surgery ● Volume 134, Number 1 107
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Dox analysis of operative categories of surgical intervention, pa-
hologies, and preoperative risk factors.
esults
oninvasive preoperative diagnosis by means of 2-dimen-
ional and Doppler echocardiography (associated or not
ith other noninvasive techniques) was possible in 530
61.9%) patients. Cardiac catheterization in association with
oninvasive techniques was used in 273 (31.8%) patients, in
9 (4.5%) patients diagnosis was made by means of cardiac
atheterization only, and magnetic resonance imaging was
ufficient in 13 (1.5%) patients. No data were available for
patient.
According to the preoperative clinical and instrumental
valuation, 294 (34.6%) patients were classified in NYHA
unctional class I, 412 (48.4%) in class II, 120 (14.2%) in
lass III, and 24 (2.8%) in class IV (2.8%). No data were
vailable for 7 patients.
Preoperative electrocardiography showed sinus rhythm
n 83% of patients. Major arrhythmias included atrial fibril-
ation in 55 (6.4%) patients, supraventricular tachyarrhyth-
ias in 13 (1.5%) patients, complete atrioventricular block
n 10 patients (1.1%), and atrial flutter in 6 patients (0.7%).
o data were available in 75 patients (8.8%).
Associated extracardiac anomalies were present in 40
atients and included Marfan syndrome in 19 (2.3%), Down
yndrome in 12 (1.4%), Williams–Beuren syndrome in 3
0.3%), and Turner syndrome in 1. Other nonsignificant
hromosomal anomalies were found in 4 patients.
We collected 1196 “anatomic diagnoses” in 856 patients.
able E1 shows diagnoses of basic heart malformation and
iagnoses “leading to surgical intervention.”
There were 1179 surgical procedures performed in 856
atients in 7 centers (mean, 122.3 procedures per center;
ange, 34-334 procedures). Among these, there were 30
alliative procedures (group 1) performed in 18 patients
2.4%, Table 1), 742 repair procedures (group 2) in 628
atients (69.5%, Table 2), and 322 reoperations (Group 3) in
10 patients (27.4%, Table 3). Types of procedures are
hown in Tables 1 through 3.
Twenty-seven patients died within 30 days or before
ospital discharge (early overall mortality, 3.1%). The most
ommon causes of death were low cardiac output syndrome
n 13 (1.5%) patients, bleeding in 3 patients, and sepsis in 2
atients. The palliation group presented with the highest
arly mortality (16.6%) when compared with group 2
1.3%) and group 3 (7.6%). Main causes of death are listed
n Table E2.
Mean intensive care unit stay was 2.3 days (range, 1-102
ays): 5.2 days in group 1, 1.8 days in group 2, and 3.5 days
n group 3. Postoperative complications were reported in
47 (28.8%) patients. The most common complications
ncluded postoperative arrhythmias (64 events), low cardiac
utput syndrome (28 events), bleeding requiring reoperation c
08 The Journal of Thoracic and Cardiovascular Surgery ● July24 events), pleural effusion requiring drainage (19 events),
ostoperative mechanical ventilation for more than 7 days
17 events), and pneumothorax (10 events). Postoperative
rrhythmia and bleeding were the most common complica-
ions in group 2, whereas in groups 1 and 3 low cardiac
utput syndrome complicated the postoperative course more
ommonly (Table E2). Seven patients, the majority of
hom were younger than 30 years, were started unsuccess-
ully on mechanical circulatory support devices.
Cardiac rhythm at the moment of discharge from the
ospital showed 90.5% of patients with sinus rhythm by
eans of electrocardiography, whereas 2.5% showed
trial fibrillation, 0.8% (7 patients) showed complete
trioventricular block, and 2 patients showed atrial flut-
er. This compares favorably with preoperative electro-
ardiographic data; however, these differences were not
tatistically significant. In addition, CAVB incidence is
educed because 3 of the patients affected died at the time
f the operation (Table E3).
ollow-up
he follow-up period ranged from 1 month to 5.2 years
mean, 21.8 months; median, 18.9 months). Follow-up com-
leteness was 87% (744/856 patients).
Overall, there were 48 adverse events among survivors,
ith arrhythmias and chest effusions (pleural or pericardial)
eing the most common. Late cardiac death occurred in 4
0.46%) patients; in one additional case death was non–
ardiac related. Reoperation was necessary in 9 (1%) pa-
ients, consisting mainly of valve replacement (2 patients)
nd pacemaker implantation (2 patients); heart transplanta-
ion was performed in 1 patient. Interventional cardiology
rocedures were done in 5 (0.5%) patients and were mainly
ntiarrhythmia procedures (3 patients). All data are exposed
n Table E4.
At latest follow-up, 79.3% of the patients are in NYHA
lass I, 17.6% are in class II, 2.9% are in class III, and only
patient is in class IV (corrected transposition of the great
rteries after pulmonary artery banding and mitral valve
lasty). The ability index is estimated as grade I in 82.4%,
rade II in 13.7%, and grade III in 2.3%. None were found
o be in ability index grade IV. Data were not available in
.6% of patients.
tatistical Analysis
verall survival at 5 years for all procedures is 96%. Sur-
ival curves according to Kaplan–Meier analysis are shown
n the following figures.
Survival estimate is 82.6% at 4 years for palliation pro-
edures, 98.9% for repair, and 91.8% for reoperation at 5
ears (P  .0001, Figure 1).
Survival estimate for patients in preoperative NYHA
lass IV associated or not with cyanosis is significantly
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Dower versus that seen in other patients (70% and 92.3% vs
7.1%, P  .0001, Figure E1).
Survival estimate for patients in preoperative NYHA
lass III is significantly lower versus that seen in other
atients (97.1% vs 90.4%, P  .012, Figure E2).
Survival estimate is 99.7% at 5 years for patients with
SD and 93.5% at 5 years for all other pathologies (P 
0001, Figure E3).
Survival estimate for patients with single-ventricle phys-
ology is 75% versus 97% for those without single-ventricle
hysiology (P  .0001, Figure E4); however, there is no
ignificant difference for these patients when considered by
urgical category (P  .24, Figure E5).
Survival estimate for patients with a right heart lesion is
2.8% versus 97.2% for patients without (P  .023, Figure
6); in addition, survival in patients with a right heart lesion
y category is 77.8% for palliation, 95.9% for repair, and
1.2% for reoperation (P  .0292, Figure E7).
Survival estimate for patients with a left heart lesion is
8.9% versus 95.3% for patients without a lesion (P  .05,
igure E8); however, there is no significant difference for
hese patients when considered by category (P  .0884),
igure E9.
Survival estimate is 97.4% at 5 years for preoperative
cyanotic patients and 88.8% at 5 years for preoperative
Figure 1. Kaplan–Meier survivyanotic patients (P  .0001 (Figure 2). n
The Journal of ThoracicOverall freedom from adverse events is 88% at 5 years
Figure 3).
Freedom from any kind of adverse event is 91% for
oncyanotic patients versus 63.9% at 5 years (P  .0001,
igure E10).
Multivariate Cox analysis identifies the following param-
ters among the most powerful incremental risk factors: (1)
reoperative NYHA class IV in cyanotic patients (HR, 8.6;
 .001); (2) preoperative NYHA class III (HR, 2.7; P 
023); (3) single-ventricle physiology as a preoperative di-
gnosis (HR, 2.6; P  .032); and (4) reoperation (HR, 2.3;
 .029).
According to multivariate Cox analysis, the most pow-
rful decremental risk factors are (1) ASD diagnosis (HR,
.08; P  .0018) and (2) left heart lesion diagnosis (HR,
.16; P  .014).
iscussion
ery few patients with CHD can survive to adult age
ithout surgical intervention. Since the late 1960s, the
uccess of cardiac medical and surgical therapy has drasti-
ally modified the natural history of almost all CHDs. This
mprovement has selected a growing number of newborns
nd infants who have survived through adolescence until
dulthood. These adults constitute a new medical commu-
timates by surgical category.al esity that is commonly called Grown-up Congenital Heart
and Cardiovascular Surgery ● Volume 134, Number 1 109
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Disease4 or adult CHD.5 In the year 2000, the number of
dult patients with CHD was calculated to be equal to the
umber of pediatric patients, and it is expected that 20 years
rom now, the number of adult patients with CHD will
xceed those in pediatric care by a considerable margin.1,6
ased on an English study model,7 it is expected that in
taly there are currently 60,000 to 100,000 adult patients
ith CHD requiring follow-up.2
The effect of such a peculiar group of patients on the
edical community is relevant. This population of adults
as special needs and peculiar problems.1,2,4,8 As outlined
y Warnes,9 despite great advances in diagnosis and therapy
ccurring in the last decades, many intracardiac repairs and
irculations might still not function normally. Residual
roblems are common, and they might need a lifelong
ollow-up, with appropriate treatment and care, either med-
cal or surgical.
Somerville4 estimates that almost 20% of admissions to
so-called Grown-up Congenital Heart disease unit are for
urgical indications. Adult patients are usually referred for
urgical intervention because of an increase in symptoms
hat is not controllable with medical therapy.4 In our expe-
ience, before surgical intervention, the majority of patients
ave been in NYHA class I or II, and surgical intervention
Figure 2. Kaplan–Meir survivalas dictated more by the existing diagnosis than symptoms, d
10 The Journal of Thoracic and Cardiovascular Surgery ● Julyith the aim of restoring the normal circulation and modi-
ying the natural history of CHD.
The analysis of data collected in our multicenter study
ndicates that cardiac surgery in patients with adult CHD
as been characterized by a relatively low overall operative
ortality (3.1%). This is comparable with our previous
eported European experience of 2.4%3 and considerably
ower than 6.3%, as reported by Srinathan and colleagues.10
t is of note, however, that we are analyzing patients who,
requently, were preoperatively in good clinical condition
NYHA class I or II in the majority), and ASD was un-
oubtedly a very common “leading to surgical intervention”
iagnosis. This has certainly influenced our good early
utcome. For this reason, in our analysis we have extrapo-
ated the survival for patients with a diagnosis other than
SD, and we have found that in this selected group, mor-
ality is still inferior to 6%. This might support the common
eeling that precocious diagnosis and surgical treatment
efore irreversible cardiac decompensation and onset of
evere symptoms is a rational strategy to improve results.
In addition, our statistical analysis shows an estimated
umulative survival of 96% at 5 years; when considered by
ategory, it is higher for complete repair (98.9%) compared
ith reoperations (91.8%) and palliation (82.6%). Thus
ates by preoperative cyanosis.estimespite repair of congenital heart defects being performed
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Dater than the “proper time,” this can still be carried out with
relatively low mortality risk.
In our experience the most represented group is the
epair group (group 2), which shows excellent operative
esults in the early and midterm periods. This is generally
rue also for patients with single-ventricle anatomy who
ave undergone a physiologic correction by means of a
ontan repair and one-and-half-ventricle repair. However,
ur analysis demonstrates that single-ventricle diagnosis is
till a considerable risk factor for mortality in the midterm
HR, 2.6; P  .032).
As reported by Srinathan and colleagues,10 it can be
xpected that the rate of first repair in adults will decrease as
ime goes by, whereas redo operations will represent the
ajor portion of these procedures in the near future. About
0% of lesions undergoing repair in our series consisted of
SDs. It is surprising that such a large population of pa-
ients in our country are still undergoing surgical, rather
han transcatheter, device closure. We could not identify a
pecific reason in this matter. However, despite presumed
dvantages of percutaneous closure in adults,11 our experi-
nce shows excellent early and midterm results, either in
erms of mortality or clinical improvement, with no opera-
ive risk. In light of these results, we believe that especially
Figure 3. Overall freen those patients with a history of transitory ischemic attack c
The Journal of Thoracicr neurological deficit caused by patency of foramen ovale,
trial septal aneurysm, or coagulation disorders, ASD sur-
ical closure still plays an important role in avoiding the
ersistence of artificial conditions linked to device implan-
ation. Longer follow-up is certainly needed in these pa-
ients to outline occurrence of arrhythmic events that are
ften causes of important morbidity in the long term.12
Group 1 (palliation) is the least represented group but
resents with the worse results. It is predictable that pallia-
ive procedures will soon decrease in number because pa-
ients with cyanotic CHDs currently undergo repair in early
nfancy, with the aim of correcting or avoiding long-term
yanosis. A palliative procedure as an adult is still under-
aken to improve temporarily the clinical status in patients
ith no chance for correction or other substitutive type of
peration. A considerable rate of nonfatal complications has
oomed the palliation group either in the postoperative
ourse or in the follow-up period. This is predictable be-
ause we know that preoperative cyanosis is an important
isk factor for early and midterm outcome of patients with
dult CHD.3,10,13 The reason for this common finding is the
xistence of complex pathology, additional collateral pul-
onary and mediastinal vascularization, bleeding disorders,
nd impaired cardiac function.14 Our statistical analysis
from adverse events.domonfirms these data and underlines that when cyanosis is
and Cardiovascular Surgery ● Volume 134, Number 1 111
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Dssociated with NYHA functional class IV or diagnosis of
ransposition of the great arteries, the patient has an ex-
remely high risk, accounting for HRs of 8.6 and 5.0,
espectively.
As the number of patients who are treated for CHD in
ediatric age is increasing around the world, a new emerg-
ng class is that of adult patients who are now facing the
ong-term effects of a residual congenital defect, the se-
uelae of the treatment, or both. Many of them do need a
eoperation after primary repair. Limited knowledge exists
n optimal timing for reoperations, perioperative risk fac-
ors, and long-term benefits. Surgical mortality in this subset
f patients varies between 5.6% and 8.6%.10,13,15,16 In our
xperience early mortality of 7.6% is higher than for repair,
nd reoperation is associated with an HR of 2.3. In this
roup of patients, the intrinsic risk of intraoperative hem-
rrhage, postoperative hemorrhage, or both by redo sternot-
my and management of adherences has to be taken into
ccount. However, redo sternotomy has not been a cause of
eath in our experience. These patients are often in a more
ompromised preoperative clinical status, and as expected,
hey present with a high frequency of postoperative com-
lications (42.4% in the series of Berdat and coworkers13
nd 36.4% in ours). As also outlined by others,10,15,16 in our
xperience postoperative low cardiac output syndrome has
een the main complication and cause of death in this
ubgroup. This finding confirms the current opinion that
onditions that might have a negative effect on cardiac
unction, such as heart failure as an indication for reopera-
ion or cyanosis, are identified as additional risk factors for
ostoperative death.10 In addition, we are inclined to think
hat some of these patients might have benefited from earlier
ntervention before irreversible myocardial deterioration
as established, as proposed by some authors.17
Diller and associates18 have recently reported that exer-
ise capacity is decreased in patients with adult CHD as in
atients with chronic heart failure, even in mildly symptom-
tic patients. This retrospective analysis performed in 335
atients with heterogeneous CHD points out the concept
hat patients with adult CHD represent a very complex
roup of patients and that even when asymptomatic they
ide a less than normal cardiac situation. For this reason, we
hink that if surgical intervention is meant to be of some
elp for these patients, 2 things have to be kept in mind: (1)
urgical intervention should be performed before it is too
ate, and therefore surgical indication should be precocious,
nd (2) it is legitimate to think that postoperative intensive
are knowledge in this field needs to be improved to be
eady to face this increasing group of demanding patients. A
evoted team of caregivers have to be well trained to treat
hese complex patients appropriately. This complex popu-
ation is estimated to grow 5% per year.19 Thus it is imper-
tive that the medical community soon structures a func-
12 The Journal of Thoracic and Cardiovascular Surgery ● Julyional care network for adult CHD based on clinicians and
urgeons with an adequate training and knowledge of CHD
nd physiology, together with knowledge of the problems of
dult patients. As described by some authors,20 care should
e specialized in devoted hospital units where a complete
eam of cardiologists, congenital cardiac surgeons, a heart
nd heart-lung transplant team, intensive care specialists,
nesthesiologists, and also endocrinology, gynecology, and
sychiatry specialists should be involved. In addition, the
rimary caregiver should be trained in following these pa-
ients so as to ensure a close contact with patients.20
In conclusion, the outcome of the surgical treatment of
HD in adults is still uncertain, and a new field is to be
iscovered. Our analysis predicts good midterm postopera-
ive outcomes that allow surgeons to be relatively optimistic
n proposing surgical treatment in this difficult category of
atients. Closer follow-up and learning the optimal surgical
iming is expected to maintain good results in the long term.
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iscussion
r Hillel Laks (Los Angeles, Calif). Thank you, Dr Jonas, Dr Kron.
would like to thank the association for the invitation to discuss this
rticle and Dr Padalino for sharing his manuscript and information
ith us.
I think this is an important article because it allows us to focus a
ittle bit on the issue of the place of adult CHD in the training of
urgeons, the qualification of centers and surgeons who do this kind of
peration, and the importance of analyzing outcomes in multicenter
tudies, because for most centers, the available numbers are not
nough to really analyze them. Dr Padalino and his group from Italy
ave shown that in 7 centers approximately 34 cases were done per
ear per center, but there are obviously some who had much larger
olumes than others. I wanted to ask: what were the types of centers,
ow many were children’s hospitals, how many were general hospi-
als operating on children and adults, and how many were pure adult
ospitals? In the Euro Cardio Survey, they found that of 71 centers
hat participated, 48 were considered referral centers, and of those 48,
ccording to the Euro Survey Committee, only one fifth were con-
idered as qualified to do adult congenital heart surgery. I think that
ssociations and the population of surgeons needs to consider what is
equired for the training of a surgeon to do adult CHD and what is
equired for a center.
It is not too dissimilar to the situation with transplantation, where
t is now recognized that a center requires not just a surgeon who can
o the operation but a full team of specialists, nurses, and anesthesi-
logists and infrastructure to take care of very complex patients.
The numbers of these patients is increasing as the survivals have
ncreased, and in Italy the number is estimated to be about 80,000
atients. In the United Kingdom, with about the same population, it is
stimated that there were about 145,000 patients in 2000, and it is
stimated that by the year 2010 there will be 185,000 patients with
dult CHD. In the United States the estimate is 800,000 patients,
ecognizing that of live births with CHD, about 1.5 per 1000 are
imple and 4.5 per 1000 complex. And as our results improve for the
omplex patients, more of them are surviving into adulthood and
resenting us with the kind of problems that you describe. At UCLA
e have done approximately 55 on average over the last 5 years of
dult CHDs per year, and virtually none of them nowadays, with
atheter techniques, are ASDs. Most of them are more complex.
bout 5% of our 1500 transplantations are for patients with CHD.
lthough in a center that is doing 1000 or 900 cases a year this is not
very large percentage of the volume, similar to transplantation, it
oes require a concentration of resources.
My other question for you is in view of the prevalence of therrhythmias, both as postoperative complications and late morbid- i
The Journal of Thoracicty. Are the centers doing prophylactic maze procedures and in-
erting AICDs to affect this early and late morbidity and mortality?
My last question concerns the numbers of patients referred for
eart transplantations, double-lung and heart-lung transplantations,
nd how many of these centers are also transplantation centers?
I would like to congratulate you for a very excellent presentation
nd give my thanks to the association for allowing me to discuss this.
Dr Padalino. Thanks, Dr Laks, for your nice statement. Well,
rst of all, I would like to underline that we decided to start this
tudy to evaluate the situation of resources in our country and to
ace the growing entity of this type of population, which is a very
ifficult one. Despite most of our patients being in NYHA class I
r II, we expect these patients’ conditions to become more com-
licated in the future.
As far as the centers that were involved, there are actually 7
enters that joined the study, and 50% of them are pediatric centers.
herefore they just deal with patients in the pediatric age, whereas the
emaining centers have also an adult service. The limitation in getting
he data also depends on this difference among these centers.
The same is applicable to your other question regarding the
ransplantation service; a few centers have transplantation services
nd facilities or they have government assignments to do trans-
lantation surgery. Therefore diagnoses and patients that we se-
ected might not reflect the real situation in our country.
As far as onset of arrhythmias and arrhythmia procedures, the
ain trend is to treat these patients with an ablation procedure,
ryoablation or radiofrequency ablation, when it is indicated.
owever, indication for surgery depends on the EP cardiology
ervice characteristics of each center.
As far as the heart-lung programs, heart-lung programs are not
ommon, and only a few of our referring centers are involved in a
eart-lung program. Thus they differ in the attitude they have when
hey face this kind of problem. I believe that a minority of our
enters are involved in heart-lung programs.
Dr Richard Jonas (Washington, DC). Dr. Padalino, Dr Laks
as pointed out the importance of having a team that is specialized
nd familiar with complex congenital heart problems, and many
uch teams are based in a children’s hospital. What sort of prob-
ems do you foresee in having middle-aged and elderly patients
ith congenital heart problems managed in a children’s hospital,
nd what is the best way to deal with those problems?
Dr Padalino. I believe that treating an adult patient in a pediatric
ervice can provoke a sort of inadequate treatment of adult patients,
ho also present with a lot of other problems—not only cardiologic
roblems, but frequently also psychological problems, internal med-
cine problems, and other things. Therefore, what we believe is that
ediatric cardiologists and adult cardiologists should work together in
rying to finalize the diagnosis and that the pediatric cardiac surgeon
as to be involved in the treatment of this kind of lesion because the
ediatric cardiac surgeon is the one who is in charge of the congenital
eart lesion and therefore the one who knows better the lesion and
lso the physiology.
We believe also that more adult specialists have to be involved
n the care of these patients. We think that adult congenital cardiac
atient services should be a multispecialist team, in which cardi-
logists, congenital cardiac surgeons, intensive care unit special-
sts, EP cardiologists, imaging specialists, and also internal med-
cine, gynecology, and psychiatrics divisions have to be included.
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DFigure E2. Kaplan–Meier survival esti-
mates by preoperative New York Heart
Association (NYHA) class III.
Figure E3. Kaplan–Meier survival
estimates by diagnosis of atrial sep-
tal defect (ASD).The Journal of Thoracic and Cardiovascular Surgery ● Volume 134, Number 1 113.e2
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CH
DFigure E4. Kaplan–Meier survival esti-
mates by single-ventricle diagnosis.Figure E5. Single ventricle by sur-
gical category.13.e3 The Journal of Thoracic and Cardiovascular Surgery ● July 2007
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DFigure E6. Right heart (RH) lesions. TOF, Tetralogy of Fallot; VSD, ventricular septal defect; MAPCAs, Major
aortopulmonary collateral arteries; TV, tricuspid valve; RVOT, right ventricular outflow tract; PV, pulmonary valve.The Journal of Thoracic and Cardiovascular Surgery ● Volume 134, Number 1 113.e4
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DFigure E7. Right heart lesions by surgical category. TOF, Tetralogy of Fallot; VSD, ventricular septal defect; MAPCA,
major aortopulmonary collateral arteries; TV, tricuspid valve; RVOT, right ventricular outflow tract; PV, pulmonary
valve.13.e5 The Journal of Thoracic and Cardiovascular Surgery ● July 2007
Padalino et al Surgery for Congenital Heart Disease
CH
DFigure E8. Left heart (LH) lesions. AoV, Aortic valve; MV, mitral valve; HLHS, hypoplastic left heart syndrome.The Journal of Thoracic and Cardiovascular Surgery ● Volume 134, Number 1 113.e6
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DFigure E9. Left heart lesions by category. AoV, Aortic valve; MV, mitral valve; HLHS, hypoplastic left heart
syndrome.13.e7 The Journal of Thoracic and Cardiovascular Surgery ● July 2007
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PABLE E1. A. Anatomic diagnoses
iagnosis No. %
trial septal defect 321 26.84
ortic regurgitation 98 8.19
etralogy of Fallot 73 6.10
artial anomalous pulmonary venous
connection
70 5.85
ricuspid valve disease 65 5.43
entricular septal defect 60 5.02
trioventricular septal defect 54 4.52
ubaortic stenosis 43 3.60
rrhythmia 41 3.43
unctional single ventricle 34 2.84
ortic coarctation 25 2.09
ulmonary valve regurgitation 20 1.67
ulmonary atresia 18 1.51
ulmonary stenosis 11 0.92
hysiologically corrected
transposition of the great arteries
9 0.75ther 265 21.24 O
The Journal of Thoracic aABLE E1. B. “Leading to surgical intervention” diagnoses
eading to surgical intervention
iagnosis No. %
trial septal defect 307 28.8
ortic regurgitation 99 9.29
artial anomalous pulmonary venous
connection
65 6.10
ortic stenosis 63 5.91
ricuspid valve disease 60 5.63
entricular septal defect 53 4.97
trioventricular septal defect 48 4.50
rrhythmia 44 4.39
etralogy of Fallot 34 3.19
ulmonary artery stenosis 31 2.91
onduit failure 31 2.91
itral valve regurgitation 31 2.91
ulmonary stenosis 29 2.72
ortic aneurysm 27 2.53
unctional single ventricle–Fontan 26 2.44
ortic coarctation 24 2.25
ulmonary atresia 6 0.76
hysiologically corrected
transposition of the great arteries
2 0.20ther 81 7.60
nd Cardiovascular Surgery ● Volume 134, Number 1 113.e8
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DABLE E2. Early outcome per group
Palliation
(18 patients)
Repair
(628 patients)
Reoperation
(210 patients)
Total
(856 patients)
arly death 3 (16.6%) 8 (1.27%) 16 (7.6%) 27 (3.1%)
arly death, LCO Sdr 1 3 9 13
ajor postoperative complications 13 138 81 247
Arrhythmias 1 53 10 64
LCO Sdr 5 10 13 28
Bleeding 0 13 11 24
Sternum left opened 0 1 6 7
Unplanned reoperation during same admission 1 8 1 10
Postoperative VAD/ECMO 1 2 4 7
Postoperative AV block requiring permanent PM 0 7 3 10
Prolonged mechanical ventilation 1 6 10 17
Postoperative cardiac arrest 1 2 1 4
Acute renal failure requiring temporary dialysis 1 0 0 1
Pleural effusion requiring drainage 2 8 9 19
Pneumothorax 0 10 0 10
Other minor 15 18 13 46
CU stay (mean, d) 5.2 1.8 3.5 2.3
CO Sdr, Low cardiac output syndrome; VAD, ventricular assist device; ECMO, extracorporeal membrane oxygenator; AV, atrioventricular; PM, pacemaker;
CU, intensive care unit.ABLE E3. Preoperative and postoperative electrocardio-
raphic findings
CG rhythm Preoperative (%) Postoperative (%)
inus 83 90.5
trial fibrillation 6.4 2.5
-V block, third degree 1.1 0.8*
trial flutter 0.7 0.2
o available data 8.8 6.0
CG, Electrocardiographic; A-V, atrioventricular. *Three patients affected
ied at the time of the operation.ABLE E4. Late outcome per group
dverse events
Palliation
(17 survivors)
Repair
(620 survivors)
Reoperation
(194 survivors)
ate death, cardiac / 3 1
ate death, noncardiac / 0 1
eoperation 2 4 3
nterventional 1 2 2
ther (eg, arrhythmias
and pleural
effusions)
5 21 3otal 8 30 10
13.e9 The Journal of Thoracic and Cardiovascular Surgery ● July 2007
